{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:32:20Z","timestamp":1755797540639,"version":"3.44.0"},"reference-count":3,"publisher":"American College of Physicians","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.7326\/annals-25-02787-jc","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:01:06Z","timestamp":1754341266000},"page":"JC90","source":"Crossref","is-referenced-by-count":0,"title":["In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wk"],"prefix":"10.7326","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0594-8576","authenticated-orcid":false,"given":"Alena","family":"Shantsila","sequence":"first","affiliation":[{"name":"University of Liverpool, Liverpool Centre for Cardiovascular Sciences, Liverpool, England, UK (A.S., G.Y.L.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool Centre for Cardiovascular Sciences, Liverpool, England, UK (A.S., G.Y.L.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ANNALS-25-02787-R1","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269-1324. [PMID: 29133354]","DOI":"10.1161\/HYP.0000000000000066"},{"key":"ANNALS-25-02787-R2","doi-asserted-by":"crossref","unstructured":"Desai R, Park H, Brown JD, et al. Comparative safety and effectiveness of aldosterone antagonists versus beta-blockers as fourth agents in patients with apparent resistant hypertension. Hypertension. 2022;79:2305-2315. [PMID: 35880517]","DOI":"10.1161\/HYPERTENSIONAHA.122.19280"},{"key":"ANNALS-25-02787-R3","doi-asserted-by":"crossref","unstructured":"Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318. [PMID: 16432039]","DOI":"10.1161\/01.HYP.0000201443.63240.a7"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-25-02787-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-25-02787-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:02:08Z","timestamp":1755550928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-25-02787-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.7326\/ANNALS-25-02787-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-25-02787-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"type":"print","value":"0003-4819"},{"type":"electronic","value":"1539-3704"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}